Specify a stock or a cryptocurrency in the search bar to get a summary
Harbin Pharmaceutical Group Co Ltd
600664Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trading of pharmaceuticals in China and internationally. The company offers pharmaceutical products for blood and hematopoietic, antineoplastic and immunomodulatory, respiratory, anti-inflammatory and analgesic, and chronic diseases, as well as mineral supplements, Chinese medicines, and antibiotics. It offers its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. The company is based in Harbin, China. Address: No. 7, Qunli Avenue, Harbin, China, 150070
Analytics
WallStreet Target Price
157.99 CNYP/E ratio
16.5833Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600664
Dividend Analytics 600664
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 600664
Stock Valuation 600664
Financials 600664
Results | 2019 | Dynamics |